Mast Energy Developments PLC

(Incorporated in England and Wales)

(Registration Number: 12886458)

LEI :213800HFVHGJ9YGO9F71

Share code on the LSE: MAST

ISIN: GB00BMBSCV12

('MED' or 'the Company')

8 July 2025

Mast Energy Developments PLC

Results of General Meeting 

Mast Energy Developments PLC ("MED" or "the Company") the UK-based multi-asset owner, developer, and operator in the rapidly growing Flexible Generation Power market, announces the results of voting at its General Meeting ("GM") held today. 

Proxies were received by shareholders holding 31.14% of the shares in MED (426,354,067 shares issued and outstanding).  All resolutions were passed.

Pieter Krügel, MED CEO, commented: "We are delighted that the Company's shareholders support our plan to complete the Equity Fundraise, by approving the capital reorganisation which is a key condition to closing. With this condition now satisfied, the only remaining key condition is the approval and publication of the Supplemental Prospectus, which we expect to happen shortly. Following the successful satisfaction of the conditions to the Equity Fundraise, we expect the transaction to complete shortly thereafter. We are looking forward to updating the market with further positive news in this regard over the coming days."

The proxy voting details at the GM are shown on the table below:

Admission of Consolidated Share Capital

Following the passing of all resolutions at today's GM and pending receipt of stamped approval of the Prospectus by the FCA expected shortly, the Company will immediately make application to the LSE and FCA for the newly consolidated share capital to be re-admitted to the LSE which is expected to occur on or around 14 July 2025. Application will be made for the admission of 10,658,851 new Ordinary Shares of par value £0.001 each (the "Admission"). The updated expected timetable of events from here is shown on the table below.

EXPECTED TIMETABLE OF EVENTS

The Company will update shareholders by RNS announcement, should there be any changes to the above timetable.

The ISIN for the New Ordinary Shares will be GB00BNG90H86 (SEDOL: BNG90H8) and the
LSE TICKER will remain as: MAST.

Share Information

Total Voting Rights

Application will be made to the London Stock Exchange for admission of the 10,658,851 New Ordinary Shares to trading on LSE ("Admission"). It is expected that Admission will become effective and dealings in the New Ordinary Shares will commence at 8.00 a.m. on or around 14 July 2025.

Following Admission, the total number of Ordinary Shares in the capital of the Company in issue will be 10,658,851 with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's share capital pursuant to  the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Capitalised terms used in this announcement have the same meaning as those given to them in the 16 June 2025 RNS announcement (Notice of General Meeting) unless otherwise defined.

Stay up to date with MED's latest news and updates by joining our emailing list and social media channels, as follows:

MED emailing list - https://www.med.energy/contact

MED LinkedIn page - https://uk.linkedin.com/company/mast-energy-developments-plc

MED X (formerly Twitter) handle - @mastplc

ENDS

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ('UK MAR'). Upon the publication of this announcement, this inside information is now considered to be in the public domain.